Research and Practice in Thrombosis and Haemostasis · 2018 · 96 citations · 51 references
MedicineHematologyInternal MedicineEarly DetectionPulmonologyRisk AssessmentPulmonary EmbolismThromboembolic DiseaseThrombosisThrombosis PreventionVenous DiseaseVenous ThromboembolismBurdenDisease Burden AnalysisGlobal Burden EstimationPharmacologic ThromboprophylaxisPulmonary Embolism Risk StratificationSubsegmental Pulmonary EmbolismThromboprophylaxis In Medical InpatientsVenous Thromboembolism Epidemiology
Venous thrombosis is a major contributor to the global disease burden. In this review we aim to answer two important questions: (1) are we making progress in reducing this disease burden and (2) how can we further improve? To answer these questions, we first evaluated the disease burden, that is, the incidence of first venous thrombosis over the past decade(s) and discuss its most important determinants. We found that the incidence of first venous thrombosis remained relatively unchanged, despite an increase in risk factor prevalence and a rise in identification of subsegmental pulmonary emboli due to enhanced image quality and utilization. This is, however, balanced by improved thromboprophylaxis strategies, resulting in an overall unchanged venous thrombosis incidence. We can further improve by developing, validating, and implementing risk assessment strategies, allowing us to identify persons at high or low risk in whom thromboprophylaxis can be provided or withheld, respectively.
51
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Antithrombotic Therapy for VTE Disease
Clive Kearon, Elie A. Akl, Joseph Ornelas et al. · CHEST Journal · 2016 · 4.8K citations
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14